# A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

> **NCT06041022** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 1000 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **OTHER:** Exposure factors

## Key facts

- **NCT ID:** NCT06041022
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2023-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06041022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06041022, "A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06041022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*